Meta Health Limited: Net Profit Declined by 82.6% in FY2024

Business Description

Meta Health Limited is a Singapore-based company that operates in the healthcare industry. The company has two business segments: the Metal business and the Healthcare business. The Metal business was discontinued in the previous year, and the company’s only operating clinic in the Healthcare business was closed in October 2024. [[1]]

Financial Analysis

Based on the audited financial statements for the financial year ended 31 December 2024 (FY2024), the following key points were observed:

Income Statement

– The Group reported a loss for the year of \$1,447,974 in FY2024, compared to a loss of \$8,341,834 in the previous year. [[1]] – The company did not declare any dividends for FY2024. [[1]]

Balance Sheet

– As of 31 December 2024, the Group reported net liabilities of \$1,687,051 and net current liabilities of \$1,652,133. [[1]] – The Company reported net liabilities of \$2,284,051 and net current liabilities of \$2,349,832 as of the same date. [[1]]

Cash Flow Statement

– The Group reported net cash used in operating activities of \$1,092,785 in FY2024. [[1]] – The Group had no available credit facilities as of the reporting date. [[1]]

Key Findings and Recommendations

The financial statements of Meta Health Limited indicate significant financial challenges facing the company. The net loss, negative net worth, and negative cash flow from operations raise substantial doubts about the company’s ability to continue as a going concern. [[1]]

Recommendation for Current Shareholders

Based on the financial performance and position of the company, we recommend that current shareholders consider selling their shares. The company’s financial outlook is highly uncertain, and there are no clear indications of a turnaround in the near future.

Recommendation for Potential Investors

We do not recommend investing in Meta Health Limited at this time. The company’s financial condition and future prospects are highly uncertain, and the risks outweigh the potential rewards for new investors.

Disclaimer

This report is based solely on the information provided in the audited financial statements of Meta Health Limited for the financial year ended 31 December 2024. The recommendations made in this report are the opinions of the analyst and do not constitute investment advice. Investors should conduct their own due diligence and seek professional financial advice before making any investment decisions.

View Meta Health Historical chart here